Hierarchical modelling of immunoglobulin coated bacteria in dogs with chronic enteropathy shows reduction in coating with disease remission but marked inter-individual and treatment-response variability

Mart&#237;nez-L&#243;pez, LM; Perez-Gonzalez, A; Washington, EA; Woodward, AP; Roth-Schulze, AJ; Dandrieux, JRS; Johnstone, T; Prakash, N; Jex, A; Mansfield, C

Author(s): Martínez-López, LM; Perez-Gonzalez, A; Washington, EA; Woodward, AP; Roth-Schulze, AJ; Dandrieux, JRS; Johnstone, T; Prakash, N; Jex, A; Mansfield, C;
Details: Publication Year 2021,Volume 16,Issue #8,Page e0255012
Journal Title: PLoS One
Abstract: Chronic enteropathies are a common problem in dogs, but many aspects of the pathogenesis remain unknown, making the therapeutic approach challenging in some cases. Environmental factors are intimately related to the development and perpetuation of gastrointestinal disease and the gut microbiome has been identified as a contributing factor. Previous studies have identified dysbiosis and reduced bacterial diversity in the gastrointestinal microbiota of dogs with chronic enteropathies. In this case-controlled study, we use flow cytometry and 16S rRNA sequencing to characterise bacteria highly coated with IgA or IgG in faecal samples from dogs with chronic enteropathy and evaluated their correlation with disease and resolution of the clinical signs. IgA and IgG-coated faecal bacterial counts were significantly higher during active disease compared to healthy dogs and decreased with the resolution of the clinical signs. Characterisation of taxa-specific coating of the intestinal microbiota with IgA and IgG showed marked variation between dogs and disease states, and different patterns of immunoglobulin enrichment were observed in dogs with chronic enteropathy, particularly for Erysipelotrichaceae, Clostridicaceae, Enterobacteriaceae, Prevotellaceae and Bacteroidaceae, families. Although, members of these bacterial groups have been associated with strong immunogenic properties and could potentially constitute important biomarkers of disease, their significance and role need to be further investigated.
Research Division(s): Bioinformatics; Population Health And Immunity
PubMed ID: 34411114
Publisher's Version: https://doi.org/10.1371/journal.pone.0255012
Open Access at Publisher's Site: https://doi.org/10.1371/journal.pone.0255012
Terms of Use/Rights Notice: Refer to copyright notice on published article.
Documents: journal.pone.0255012.pdf - (2.81MB, application/pdf)

Creation Date: 2021-09-17 11:04:12

Last Modified: 2021-09-17 11:18:44